Skip to content

Clinical trials

Gastroesophageal Reflux trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Not applicable Clear all

443 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20035
20045
20059
200611
200710
200811
200910
201015
201111
201215
201318
201418
201519
201629
201718
201816
201920
202017
202122
202236
202324
202427
202533
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215
Unknown status67
Recruiting57
Terminated31
Not yet recruiting28
Withdrawn24
Active, not recruiting12
Enrolling by invitation7
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic14
Asian Institute of Gastroenterology, India8
Universitaire Ziekenhuizen KU Leuven7
Chinese University of Hong Kong6
Edwards Lifesciences6
EndoGastric Solutions5
Johns Hopkins University5
Vrije Universiteit Brussel5
General Public Hospital Zell am See4
McMaster University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux443
Obesity25
Barrett Esophagus22
Heartburn22
Hernia, Hiatal20
Dyspepsia15
Obesity, Morbid15
Esophagitis12
Non-Erosive Reflux Disease11
Constipation10

Trials

Showing 1 to 25 of 443. Each trial links to its page on Pharma Observatory.

343 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.